Lunit, a medical AI company, announced on the 18th that it has signed a strategic collaboration agreement with AstraZeneca to develop an AI digital pathology solution targeting non-small cell lung…

Celltrion announced on the 15th that it has acquired the Swiss pharmaceutical distribution company "iQone Healthcare Switzerland." The acquisition process was completed this month, with the…

"By the 2030s, I envision Alteogen joining the ranks of companies with annual revenue in the trillions of won. We’ll see significant revenue from royalties and milestone payments tied to our…

Hugel Inc., a leading global medical aesthetics company, said on Wednesday it had recently launched H.E.L.F. Global Expert Workshop on hyaluronic acid dermal filler treatment for about 10 French…

Alteogen is advancing in the development of the world’s first subcutaneous (SC) injection for antibody-drug conjugates (ADCs). On the 8th, Alteogen announced it signed an exclusive licensing…

For the first time since its founding, Hugel has exceeded 100 billion KRW in quarterly revenue and 50 billion KRW in quarterly operating profit. On the 6th, Hugel, a total medical aesthetics…

Huons is set to expand its biopharmaceutical R&D and contract development and manufacturing organization (CDMO) services with its acquisition of PanGen, a specialized biopharmaceutical…

The Korean Dementia Association has addressed safety concerns related to the upcoming domestic release of the Alzheimer’s treatment Leqembi (ingredient: lecanemab), stating that the side effects…

Samsung Bioepis has surpassed its total annual revenue from last year within the first three quarters of 2023. The company’s annual revenue is projected to exceed 1.4 trillion KRW (approx. $1…

Boryung is getting closer to achieving 1 trillion KRW ($740 million) in annual sales for the first time, supported by strong third-quarter results. Its growth has been boosted by its co-promotion and…